Note 9 - Segment Information

3 Months Ended

Sep. 30, 2014

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

Note 9. Segment Information

The basis for presenting segment results generally is consistent with overall Company reporting. The Company reports information about its operating segments in accordance with GAAP which establishes standards for reporting information about a company’s operating segments.

The Company has divided its operations into three reportable segments as follows: Contract Manufacturing, Branded Proprietary Products and Other Nutraceutical Businesses. The international sales, concentrated primarily in Europe and Canada, for the three months ended September 30, 2014 and 2013 were $2,283 and $3,085, respectively.

Financial information relating to the three months ended September 30, 2014 and 2013 operations by business segment are as follows:

		Sales, Net						Segment
		U.S.		International				Gross				Capital
		Customers		Customers		Total		Profit		Depreciation		Expenditures
Contract Manufacturing	2014	$	5,743	$	2,065	$	7,808	$	1,151	$	60	$	351
	2013		5,429		2,862		8,291		1,366		66		-
Branded Proprietary Products	2014		129		210		339		6		-		1
	2013		132		160		292		57		1		-
Other Nutraceutical Businesses	2014		427		8		435		144		1		-
	2013		545		63		608		174		2		2
Total Company	2014		6,299		2,283		8,582		1,301		61		352
	2013		6,106		3,085		9,191		1,597		69		2

	Total Assets as of
	September 30,		June 30,
	2014		2014
Contract Manufacturing	$	9,683	$	7,752
Branded Proprietary Products		1,553		1,781
Other Nutraceutical Businesses		1,908		2,050
Total Company	$	13,144	$	11,583